Les biomarqueurs MSCopilot® mesurés à domicile, évaluant la marche, la vision, la dextérité et la cognition, reflètent les évaluations cliniques traditionnelles.

MSCopilot® Digital Biomarkers Obtained in a Real-world Setting correlated with their Clinical Counterparts in the MS-DETECT Study

In December 2025 in Dubai, United Arab Emirates, we presented data from the MS-DETECT study on the correlation between MSCopilot® digital biomarkers and traditional clinical assessments in patients with multiple sclerosis. The results indicate that MSCopilot® scores obtained at home correlate with traditional scores measured in the clinic.